BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9884990)

  • 1. Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate.
    Durlach J; Bac P; Bara M; Guiet-Bara A
    Magnes Res; 1998 Dec; 11(4):323-5. PubMed ID: 9884990
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evidence exists for prophylactic magnesium sulphate as a neuroprotector in premature births].
    Wolf HT; Hegaard HK; Huusom L; Greisen G; Hedegaard M
    Ugeskr Laeger; 2011 Mar; 173(13):962-5. PubMed ID: 21453636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium sulfate for the prevention of cerebral palsy.
    Mittendorf R; Pryde PG
    N Engl J Med; 2009 Jan; 360(2):189-90; author reply 190. PubMed ID: 19129535
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnesium sulfate for preterm neuroprotection.
    Mittendorf R; Lee KS; Roizen NJ; Pryde PG
    JAMA; 2004 Feb; 291(8):940-1; author reply 941. PubMed ID: 14982906
    [No Abstract]   [Full Text] [Related]  

  • 5. Does antenatal magnesium sulfate prevent cerebral palsy in preterm infants? The final trial?
    Huusom LD; Brok J; Hegaard HK; Pryds O; Secher NJ
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1346-7. PubMed ID: 23016563
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
    Costantine MM; Weiner SJ;
    Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal pharmacotherapy 3: magnesium sulfate.
    Namouz-Haddad S; Koren G
    J Obstet Gynaecol Can; 2013 Dec; 35(12):1101-1104. PubMed ID: 24405877
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*.
    Marret S; Marpeau L; Zupan-Simunek V; Eurin D; Lévêque C; Hellot MF; Bénichou J;
    BJOG; 2007 Mar; 114(3):310-8. PubMed ID: 17169012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
    Mittendorf R; Roizen NJ; Pryde PG
    J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123
    [No Abstract]   [Full Text] [Related]  

  • 10. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
    Costantine MM; Drever N
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What gestation cut-off should be used for magnesium sulfate treatment of women threatening to deliver preterm?
    Knight DB; Gardener GJ
    Am J Obstet Gynecol; 2010 Mar; 202(3):e9; author reply e9-10. PubMed ID: 19889392
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.
    Bain E; Goodchild L; Lontis R; McIntyre S; Ashwood P; Bubner T; Middleton P; Crowther C
    Aust Nurs J; 2013 Jul; 21(1):34-7. PubMed ID: 23930314
    [No Abstract]   [Full Text] [Related]  

  • 13. In defense of magnesium sulfate.
    Elliott JP; Lewis DF; Morrison JC; Garite TJ
    Obstet Gynecol; 2009 Jun; 113(6):1341-1348. PubMed ID: 19461432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocolytic magnesium sulphate and paediatric mortality.
    Bénichou J; Zupan V; Fernandez H; Marpeau L; Marret S
    Lancet; 1998 Jan; 351(9098):290-1. PubMed ID: 9457120
    [No Abstract]   [Full Text] [Related]  

  • 15. Preterm labor: approach to decreasing complications of prematurity.
    Locatelli A; Consonni S; Ghidini A
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):255-74. PubMed ID: 26002165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal magnesium sulfate for neuroprotection before preterm birth?
    Stanley FJ; Crowther C
    N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653
    [No Abstract]   [Full Text] [Related]  

  • 17. Tocolytic magnesium sulphate and paediatric mortality.
    Crowther C; Hiller J; Doyle L; Lumley J; Carlin J
    Lancet; 1998 Jan; 351(9098):291. PubMed ID: 9457121
    [No Abstract]   [Full Text] [Related]  

  • 18. Magnesium sulfate for cerebral palsy prevention.
    Rouse DJ; Gibbins KJ
    Semin Perinatol; 2013 Dec; 37(6):414-6. PubMed ID: 24290398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal magnesium sulfate and neuroprotection.
    Doyle LW
    Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers.
    Gatman K; May R; Crowther C
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):44-48. PubMed ID: 31119725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.